投資評等
最後更新日期:2024/6/9
升級(Upgrade)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 新目標價 New Target |
2009/7/13 | RBC Capital Mkts | Sector Perform >> Outperform | 38 |
2005/8/15 | CSFB | Underperform->Neutral | 45 |
2005/4/6 | Wachovia | Underperform->Mkt Perform | |
2004/12/17 | Fulcrum | Neutral->Buy | 81 |
2004/6/8 | IRG Research | Sell->Neutral | |
2004/6/7 | Merrill Lynch | Neutral->Buy | |
2004/2/27 | First Albany | Neutral->Buy | 36 |
2003/11/20 | Lehman Brothers | Equal-weight->Overweight | $35 |
2003/9/11 | First Albany | Neutral -> Buy | |
2002/9/25 | Lehman Brothers | Underweight -> Equal-weight | 19 |
2002/9/25 | Banc of America Sec | Mk -> Rerform -> Buy | |
降級(Downgrade)
日期/Date | 券商 Brokerage Firm | 原評等->降級後評等 Upgrade from: -> to: | 新目標價 New Target |
2010/3/2 | Canaccord Adams | Buy >> Hold | |
2010/3/2 | UBS | Buy >> Neutral | |
2009/6/1 | Thomas Weisel | Overweight >> Market Weight | |
2006/10/26 | Lehman Brothers | Equal-weight Underweight | |
2005/10/11 | Bear Stearns | Outperform->Peer Perform | |
2005/8/23 | Wachovia | Mkt Perform->Underperform | |
2005/7/29 | Sun Trust Rbsn Humphrey | Buy->Neutral | |
2005/3/15 | Lehman Brothers | Overweight->Equal-weight | |
2004/11/22 | Wachovia | Mkt Perform->Underperform | |
2004/4/27 | IRG Research | Neutral->Sell | |
2004/4/26 | Merrill Lynch | Buy->Neutral | |
2002/8/20 | Adams Harkness | Strong Buy -> Mkt Perform | |
2002/8/19 | Banc of America Sec | Buy -> Mkt Perform | |
首次予以評等(Coverage Initiated)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 目標股價 |
2009/6/24 | Deutsche Securities | Hold | 33 |
2009/6/19 | Oppenheimer | Perform | |
2007/12/4 | Banc of America Sec | Buy | 65 |
2006/8/4 | CE Unterberg Towbin | Buy | 43 |
2006/1/23 | Goldman Sachs | In-Line | |
2005/7/8 | Banc of America Sec | Buy | 54 |
2005/6/29 | JP Morgan | Underweight | |
2005/1/6 | UBS | Neutral | 75 |
2004/12/16 | Prudential | Neutral | 54 |
2004/12/1 | Lazard Freres | Buy | 86 |
恢復投資評等(Coverage Resumed)
日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
2003/2/14 | Merrill Lynch | Neutral | |
2002/8/5 | Adams Harkness | Strong Buy | 39 |
重申相同投資評等(Coverage Reiterated)
日期/Date | 券商 Brokerage Firm | 重申相同投資評等 Reiterated Rating | 新目標價 New Target |
2010/5/17 | RBC Capital Mkts | Sector Perform | $56 >> $57.50 |
2009/10/5 | Barclays Capital | Equal Weight | $33 >> $36 |
2009/5/15 | Barclays Capital | Equal Weight | |
2009/4/30 | UBS | Buy | |
2008/11/20 | Stanford Research | Buy | |
2007/10/26 | Lazard Capital | Buy | |
2005/11/22 | UBS | Neutral | 28 |
2005/10/12 | UBS | Neutral | 38 |
2005/8/23 | Morgan Stanley | Overweight | 60 |
2005/8/23 | Banc of America Sec | Buy | 54 |